1. Home
  2. ALOT vs EPRX Comparison

ALOT vs EPRX Comparison

Compare ALOT & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • EPRX
  • Stock Information
  • Founded
  • ALOT 1969
  • EPRX 2011
  • Country
  • ALOT United States
  • EPRX Canada
  • Employees
  • ALOT N/A
  • EPRX N/A
  • Industry
  • ALOT Computer peripheral equipment
  • EPRX
  • Sector
  • ALOT Technology
  • EPRX
  • Exchange
  • ALOT Nasdaq
  • EPRX NYSE
  • Market Cap
  • ALOT 105.3M
  • EPRX 85.5M
  • IPO Year
  • ALOT N/A
  • EPRX N/A
  • Fundamental
  • Price
  • ALOT $15.00
  • EPRX $3.37
  • Analyst Decision
  • ALOT
  • EPRX
  • Analyst Count
  • ALOT 0
  • EPRX 0
  • Target Price
  • ALOT N/A
  • EPRX N/A
  • AVG Volume (30 Days)
  • ALOT 9.1K
  • EPRX 33.3K
  • Earning Date
  • ALOT 12-12-2024
  • EPRX 11-07-2024
  • Dividend Yield
  • ALOT N/A
  • EPRX N/A
  • EPS Growth
  • ALOT 591.76
  • EPRX N/A
  • EPS
  • ALOT 0.83
  • EPRX N/A
  • Revenue
  • ALOT $150,643,000.00
  • EPRX N/A
  • Revenue This Year
  • ALOT N/A
  • EPRX N/A
  • Revenue Next Year
  • ALOT N/A
  • EPRX N/A
  • P/E Ratio
  • ALOT $17.56
  • EPRX N/A
  • Revenue Growth
  • ALOT 0.29
  • EPRX N/A
  • 52 Week Low
  • ALOT $11.83
  • EPRX $2.20
  • 52 Week High
  • ALOT $18.83
  • EPRX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 65.37
  • EPRX N/A
  • Support Level
  • ALOT $13.84
  • EPRX N/A
  • Resistance Level
  • ALOT $14.25
  • EPRX N/A
  • Average True Range (ATR)
  • ALOT 0.43
  • EPRX 0.00
  • MACD
  • ALOT 0.15
  • EPRX 0.00
  • Stochastic Oscillator
  • ALOT 100.00
  • EPRX 0.00

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: